ArticleBMC cancer2011

The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity.

Wieslawa H Dragowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.